Atria Wealth Solutions Inc. Grows Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Atria Wealth Solutions Inc. increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 21.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 42,031 shares of the company’s stock after buying an additional 7,298 shares during the period. Atria Wealth Solutions Inc.’s holdings in Cardinal Health were worth $4,255,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Aaron Wealth Advisors LLC raised its position in Cardinal Health by 1.2% during the fourth quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company’s stock worth $844,000 after acquiring an additional 97 shares during the last quarter. Schechter Investment Advisors LLC raised its position in Cardinal Health by 4.1% during the fourth quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company’s stock worth $250,000 after acquiring an additional 98 shares during the last quarter. Cypress Capital Group raised its position in Cardinal Health by 0.7% during the third quarter. Cypress Capital Group now owns 17,133 shares of the company’s stock worth $1,487,000 after acquiring an additional 111 shares during the last quarter. Monument Capital Management raised its position in Cardinal Health by 3.0% during the third quarter. Monument Capital Management now owns 4,639 shares of the company’s stock worth $403,000 after acquiring an additional 136 shares during the last quarter. Finally, Guardian Wealth Advisors LLC raised its position in Cardinal Health by 1.7% during the third quarter. Guardian Wealth Advisors LLC now owns 8,318 shares of the company’s stock worth $722,000 after acquiring an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of CAH stock opened at $103.21 on Friday. Cardinal Health, Inc. has a one year low of $77.56 and a one year high of $116.04. The company has a 50 day moving average price of $109.51 and a 200 day moving average price of $104.76. The firm has a market capitalization of $25.10 billion, a price-to-earnings ratio of 40.63, a price-to-earnings-growth ratio of 1.05 and a beta of 0.68.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, February 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. During the same quarter in the prior year, the business posted $1.32 earnings per share. Cardinal Health’s revenue for the quarter was up 11.6% compared to the same quarter last year. As a group, equities analysts forecast that Cardinal Health, Inc. will post 7.28 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.5006 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 annualized dividend and a yield of 1.94%. Cardinal Health’s dividend payout ratio is currently 78.74%.

Analyst Ratings Changes

CAH has been the subject of a number of research reports. Leerink Partnrs restated an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. Barclays began coverage on shares of Cardinal Health in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 target price for the company. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Argus raised shares of Cardinal Health from a “hold” rating to a “buy” rating in a research report on Friday, February 9th. Finally, UBS Group boosted their price objective on shares of Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $103.07.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.